
Evexia Lifecare (EVEXIA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
395.9M
Gross Profit
186.5M
47.11%
Operating Income
11.4M
2.87%
Net Income
-1.5M
-0.39%
Balance Sheet Metrics
Total Assets
9.2B
Total Liabilities
4.5B
Shareholders Equity
4.7B
Debt to Equity
0.97
Cash Flow Metrics
Revenue & Profitability Trend
Evexia Lifecare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.1B | 562.9M | 695.5M | 755.1M | 1.1B |
Cost of Goods Sold | 888.4M | 506.5M | 656.4M | 708.2M | 1.0B |
Gross Profit | 216.4M | 56.4M | 39.1M | 46.9M | 36.4M |
Gross Margin % | 19.6% | 10.0% | 5.6% | 6.2% | 3.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | 3.4M | 3.1M | 1.6M |
Other Operating Expenses | 117.9M | 27.2M | 21.8M | 13.5M | 7.2M |
Total Operating Expenses | 117.9M | 27.2M | 25.3M | 16.5M | 8.8M |
Operating Income | 23.8M | 15.6M | 1.9M | 23.0M | 19.4M |
Operating Margin % | 2.2% | 2.8% | 0.3% | 3.0% | 1.8% |
Non-Operating Items | |||||
Interest Income | - | - | 12.2M | 327.0K | 474.0K |
Interest Expense | 10.9M | 4.9M | 5.4M | 957.0K | 50.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 14.4M | 19.3M | 15.3M | 21.8M | 19.2M |
Income Tax | 5.1M | 5.5M | 8.6M | 13.1M | 6.4M |
Effective Tax Rate % | 35.2% | 28.6% | 56.4% | 60.4% | 33.3% |
Net Income | 9.3M | 13.8M | 6.7M | 8.6M | 12.8M |
Net Margin % | 0.8% | 2.4% | 1.0% | 1.1% | 1.2% |
Key Metrics | |||||
EBITDA | 42.2M | 28.4M | 24.6M | 25.5M | 42.4M |
EPS (Basic) | - | ₹0.02 | ₹0.01 | ₹0.02 | ₹0.00 |
EPS (Diluted) | - | ₹0.02 | ₹0.01 | ₹0.02 | ₹0.00 |
Basic Shares Outstanding | - | 688500000 | 666700000 | 619333330 | 619333330 |
Diluted Shares Outstanding | - | 688500000 | 666700000 | 619333330 | 619333330 |
Income Statement Trend
Evexia Lifecare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 41.4M | 7.5M | 4.8M | 15.4M | 5.1M |
Short-term Investments | 16.3M | - | - | - | - |
Accounts Receivable | 929.1M | 435.4M | 313.4M | 151.6M | 456.8M |
Inventory | 27.5M | 11.1M | 20.1M | 13.5M | 33.0M |
Other Current Assets | 76.4M | 50.3M | 415.0K | 105.0K | 1.4M |
Total Current Assets | 1.2B | 971.0M | 865.7M | 696.9M | 1.1B |
Non-Current Assets | |||||
Property, Plant & Equipment | 223.8M | 107.2M | 4.6M | 2.0M | 1.9M |
Goodwill | 549.8M | - | - | 0 | 0 |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 36.2M | 34.8M | 20.1M | 22.0M | 11.7M |
Total Non-Current Assets | 8.0B | 7.9B | 7.6B | 573.7M | 330.7M |
Total Assets | 9.2B | 8.8B | 8.5B | 1.3B | 1.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 635.9M | 270.5M | 335.2M | 241.0M | 322.9M |
Short-term Debt | 112.6M | 96.2M | 89.2M | 57.9M | 67.5M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 10.2M | 61.6M | 32.3M | 3.9M | 7.3M |
Total Current Liabilities | 793.1M | 434.6M | 465.9M | 319.0M | 524.9M |
Non-Current Liabilities | |||||
Long-term Debt | 3.7B | 6.8B | 7.0B | 0 | 229.0K |
Deferred Tax Liabilities | 1.5M | 1.5M | 1.7M | 1.1M | 0 |
Other Non-Current Liabilities | - | - | -1.0K | 2.0K | -2.0K |
Total Non-Current Liabilities | 3.7B | 7.1B | 7.1B | 146.6M | 100.4M |
Total Liabilities | 4.5B | 7.5B | 7.6B | 465.5M | 625.2M |
Equity | |||||
Common Stock | 1.9B | 708.0M | 664.4M | 619.3M | 619.3M |
Retained Earnings | - | - | 83.5M | 74.6M | 65.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 4.7B | 1.3B | 903.1M | 805.1M | 796.5M |
Key Metrics | |||||
Total Debt | 3.9B | 6.9B | 7.0B | 57.9M | 67.8M |
Working Capital | 390.9M | 536.4M | 399.8M | 377.9M | 566.1M |
Balance Sheet Composition
Evexia Lifecare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 14.4M | 19.3M | 15.3M | 21.8M | 19.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -55.1M | 28.7M | -113.8M | -28.1M | 877.3M |
Operating Cash Flow | -29.9M | 41.9M | -112.6M | -6.5M | 173.1M |
Investing Activities | |||||
Capital Expenditures | -70.4M | -2.6M | -24.5M | -24.9M | -1.9M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | -194.3M | -6.9B | 0 | -8.7M |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -99.0M | -196.9M | -6.9B | -24.9M | -10.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 28.3M | 7.0M | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 331.2M | 131.6M | - | -1.0K | 0 |
Free Cash Flow | -342.4M | 167.6M | -55.9M | -82.3M | 15.2M |
Net Change in Cash | 202.2M | -23.4M | -7.1B | -31.4M | 162.5M |
Cash Flow Trend
Evexia Lifecare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
113.50
Price to Book
0.46
Price to Sales
3.83
Profitability Ratios
Profit Margin
1.19%
Operating Margin
3.91%
Return on Equity
0.20%
Return on Assets
0.10%
Financial Health
Current Ratio
1.49
Debt to Equity
82.72
Beta
-0.14
Per Share Data
EPS (TTM)
₹0.02
Book Value per Share
₹4.94
Revenue per Share
₹1.19
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
evexia | 4.3B | 113.50 | 0.46 | 0.20% | 1.19% | 82.72 |
Nestle India | 2.2T | 72.01 | 55.96 | 79.99% | 15.21% | 29.11 |
Britannia Industries | 1.3T | 60.78 | 30.67 | 49.73% | 12.02% | 28.45 |
Gujarat Ambuja | 47.5B | 19.95 | 1.57 | 8.30% | 4.94% | 7.62 |
Gokul Agro Resources | 48.4B | 18.31 | 4.68 | 23.71% | 1.31% | 52.50 |
Gopal Snacks | 45.2B | 237.52 | 11.16 | 4.69% | -0.19% | 16.43 |
Financial data is updated regularly. All figures are in the company's reporting currency.